biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by higgsbosonon Feb 07, 2017 2:42pm

167 Views

Post# 25811795

RE:TRUMP IS IN FAVOR OF NEGOTIATING PHARMA PRICES

hoooooo geese
from brady to trump
where was brady when they where behind 28 to 3
now we have trump a narcisistic liar and that is being kind
he grabs
he lies
he insults just like on a construction site
he has no credibility
he alone can fix the worlds problems
what bs
hooooo yeah is is worth $ 10B

Bullboard Posts

Eminent acquires promising Nevada gold project